Altres línies
- Nombre de publicacions
- 604
Publicacions
-
Otal, A; Celada, F; Chimeno, J; Vijande, J; Pellejero, S; Perez-Calatayud, MJ; Villafranca, E; Fuentemilla, N; Blazquez, F; Rodriguez, S; Perez-Calatayud, J
Review on Treatment Planning Systems for Cervix Brachytherapy (Interventional Radiotherapy): Some Desirable and Convenient Practical Aspects to Be Implemented from Radiation Oncologist and Medical Physics Perspectives
Cancers 14 -. .
-
Encinas, C; Hernandez-Rivas, JA; Oriol, A; Rosinol, L; Blanchard, MJ; Bellón, JM; García-Sanz, R; de la Rubia, J; de la Guía, AL; Jímenez-Ubieto, A; Jarque, I; Inigo, B; Dourdil, V; de Arriba, F; Pérez-Avila, CC; Gonzalez, Y; Hernández, MT; Bargay, J; Granell, M; Rodríguez-Otero, P; Silvent, M; Cabrera, C; Rios, R; Alegre, A; Gironella, M; Gonzalez, MS; Sureda, A; Sampol, A; Ocio, EM; Krsnik, I; García, A; García-Mateo, A; Soler, JA; Martín, J; Arguinano, JM; Mateos, MV; Bladé, J; San-Miguel, JF; Lahuerta, JJ; Martínez-López, J
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
Blood Cancer Journal 12 -. .
-
Fuertes Abardía C; Ballesta Juan P; Cruz Esteve I; Galindo Ortego G; Marsal Mora JR; Gómez-Arbonés X
Prescripción potencialmente inadecuada: utilidad de los criterios STOPP/START versión 2 a nivel poblacional en Cataluña.
Medicina de Familia-SEMERGEN 48 163-173. .
-
Caon M; Prinelli F; Angelini L; Carrino S; Mugellini E; Orte S; Serrano JCE; Atkinson S; Martin A; Adorni F
PEGASO e-Diary: User Engagement and Dietary Behavior Change of a Mobile Food Record for Adolescents.
Frontiers in Nutrition 9 727480-727480. .
-
Bataller, A; Garrido, A; Guijarro, F; Oñate G; Diaz-Beyá, M; Arnan, M; Tormo, M; Vives, S; de Llano MPQ; Coll, R; Gallardo, D; Vall-Llovera, F; Escoda, L; Garcia-Guiñon, A; Salamero, O; Sampol, A; Merchan, BM; Bargay, J; Castaño-Díez S; Esteban, D; Oliver-Caldés, A; Rivero, A; Mozas, P; López-Guerra, M; Pratcorona, M; Zamora, L; Costa, D; Rozman, M; Nomdedéu, JF; Colomer, D; Brunet, S; Sierra, J; Esteve, J
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol.
Blood Advances 6 1193-1206. .
-
Onate, G; Bataller, A; Garrido, A; Hoyos, M; Arnan, M; Vives, S; Coll, R; Tormo, M; Sampol, A; Escoda, L; Salamero, O; Garcia, A; Bargay, J; Aljarilla, A; Nomdedeu, JF; Esteve, J; Sierra, J; Pratcorona, M
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
Blood Advances 6 882-890. .
-
Jiménez-Yuste, V; Alvarez-Román, MT; Bravo, AP; Galmes, BJ; Hernández, MDN; Hidalgo, OB; Alonso, CM; González, NFP; Coll, J; Nunez, R; Carrasco, M; Candel, FG; Gonzalez-Porras, JR; García, CH; Castro, MJV; Mir, R
Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 28 -. .
-
Granado-Serrano, AB; Martin-Gari, M; Sanchez, V; Riart Solans M.; Lafarga Giribets A.; Berdun, R; Vilaprinyo, E; Portero-Otin, M; Serrano J.C.E.
Colonic Microbiota Profile Characterization of the Responsiveness to Dietary Fibre Treatment in Hypercholesterolemia
Nutrients 14 -. .
-
Rojo-López MI; Castelblanco E; Real J; Hernández M; Falguera M; Amigó N; Julve J; Alonso N; Franch-Nadal J; Granado-Casas M; Mauricio D
Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area.
Nutrients 13 -. .
-
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Aging-US 13 22690-22709. .
-
Ribera, JM; Morgades, M; Genescà, E; Chapchap, EC; Montesinos, P; Acuna-Cruz, E; Gil, C; García-Cadenas, I; Barba, P; González-Campos, J; de Llano, MPQ; Torrent, A; Ribera, J; Granada, I; Bernal, T; Díaz-Beya, M; Amigo, ML; Coll, R; Tormo, M; Vall-llovera, F; Gómez-Centurión, I; Sánchez-Sánchez, MJ; Soria, B; Cladera, A; Artola, MT; Garcia-Guiñon, A; Giménez-Conca, A; Amador, ML; Martínez-Sánchez, P; Algarra, JL; Vidal, MJ; Alonso, N; Maluquer, C; Llorente, L; García-Boyero, R; Ciudad, J; Feliu, E; Orfao, A; PETHEMA Grp
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials
HEMATOLOGICAL ONCOLOGY 39 529-538. .
-
Genescà, E; Morgades, M; González-Gil, C; Fuster-Tormo, F; Haferlach, C; Meggendorfer, M; Montesinos, P; Barba, P; Gil, C; Coll, R; Moreno, MJ; Martínez-Carballeira, D; García-Cadenas, I; Vives, S; Ribera, J; González-Campos, J; Díaz-Beya, M; Mercadal, S; Artola, MT; Cladera, A; Tormo, M; Bermúdez, A; Vall-llovera, F; Martínez-Sánchez, P; Amigo, ML; Monsalvo, S; Novo, A; Cervera, M; García-Guiñon, A; Ciudad, J; Cervera, J; Hernández-Rivas, JM; Granada, I; Haferlach, T; Orfao, A; Solé, F; Ribera, JM
Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
LEUKEMIA RESEARCH 109 -. .
